KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Other Non Operating Income: 2009-2010

Historic Other Non Operating Income for Rigel Pharmaceuticals (RIGL) over the last 2 years, with Dec 2010 value amounting to $2.4 million.

  • Rigel Pharmaceuticals' Other Non Operating Income fell 13.31% to $15.1 million in Q1 2011 from the same period last year, while for Mar 2011 it was $16.6 billion, marking a year-over-year increase of 7325.64%. This contributed to the annual value of $2.4 million for FY2010, which is 98.32% down from last year.
  • According to the latest figures from FY2010, Rigel Pharmaceuticals' Other Non Operating Income is $2.4 million, which was down 98.32% from $140.7 million recorded in FY2009.
  • Over the past 5 years, Rigel Pharmaceuticals' Other Non Operating Income peaked at $140.7 million during FY2009, and registered a low of $2.4 million during FY2010.
  • Over the past 2 years, Rigel Pharmaceuticals' median Other Non Operating Income value was $71.6 million (recorded in 2009), while the average stood at $71.6 million.
  • Data for Rigel Pharmaceuticals' Other Non Operating Income shows a maximum YoY plummeted of 98.32% (in 2010) over the last 5 years.
  • Yearly analysis of 2 years shows Rigel Pharmaceuticals' Other Non Operating Income stood at $140.7 million in 2009, then plummeted by 98.32% to $2.4 million in 2010.